Blog

  • Carlson’s Alp Could Upend Pouch Market: Survey

    Carlson’s Alp Could Upend Pouch Market: Survey

    More than 86 percent of current U.S. nicotine pouch users say they are likely to switch to the recently launched Alp brand, according to a survey carried out by online retailer Nicokick. Such a shift would upend the nicotine pouch industry, which is currently valued at approximately $988.4 million and dominated by Philip Morris International’s Zyn brand.

    Alp was launched in November by Tucker Carlson and Turning Point Brands. The conservative commentator touts the product as “the first nicotine pouch brand made by and for adults who unapologetically love nicotine.”

    According to an earlier article in The Wall Street Journal, Carlson decided to enter the tobacco business because of the way Zyn manufacturer Philip Morris International responded to an off-color remark he made in 2023 about America’s bestselling nicotine pouch.

    It’s clear the introduction of Tucker Carlson’s brand Alp should have a significant impact on the nicotine market, not only with current pouch users, but also with consumers of other forms of smoking and tobacco products.

    Also in Nickokick’s survey, 41.4 percent of cigarette users and 53.6 percent of cigar users said they would be likely to switch to Alp nicotine pouches. Nearly 55 percent of vapers also said they would be likely to switch.

     “It’s clear the introduction of Tucker Carlson’s brand Alp should have a significant impact on the nicotine market, not only with current pouch users, but also with consumers of other forms of smoking and tobacco products,” said Marina Murphy, senior director of scientific affairs at Nicokick.

    “A shift away from cigarettes, and towards nicotine alternatives like pouches, could have impacts not only on the industry, but on the lives and health of millions of American consumers.”

  • Philippine Tobacco Farmers to Receive Cash

    Philippine Tobacco Farmers to Receive Cash

    Photo: PMFTC

    The National Tobacco Administration (NTA) of the Philippines is poised to distribute PHP100 million ($1.73 million) to qualified tobacco farmers nationwide, reports GMA News.

    The organization has identified 16,666 tobacco farmers as recipients of the cash assistance amounting to PHP6,000 each, which will be distributed on or before Dec. 15, 2024.

    The funds are intended to cover tobacco farmer-recipients’ production for cropping year 2024-2025, which began in September 2024 and will conclude by June 2025.

    The NTA said the recipients were identified by the agency’s branch offices based on the guidelines set and approved by the NTA governing board.

    Among the recipients are 9,055 contract growers and 7,611 are non-contract growers.

    The NTA said that beneficiaries of the cash assistance must be registered tobacco farmers with the agency and are personally tilling a tobacco farm “capable of providing adequate labor to attend to all activities in quality tobacco production, able to provide basic farm tools and equipment, such as plow, harrow, sprayer, work animal, irrigation pump, and curing bar/air curing shed, and should have adequate sources of good quality irrigation water and desirable for tobacco production.”

  • Report Details Global Age Verification Regulations

    Report Details Global Age Verification Regulations

    Image: Ondato

    Ondato, a global provider of digital identity and age verification solutions, has released a report that maps the intricacies of age verification regulations worldwide.

    The report analyzes age verification laws and practices across major markets, including the EU, the United States, the United Kingdom and emerging economies. It provides sector-specific insights into regulations affecting industries such as gaming, social media, e-commerce and online content streaming. Additionally, the report identifies common compliance challenges that businesses face when navigating diverse regulations and explores how technology can help mitigate these issues.

    “Our goal is to empower businesses with the knowledge and tools they need to stay compliant and protected,” said Ondato co-founder and CEO Liudas Kanapienis. “This report is an invaluable tool for companies striving to keep pace with the evolving regulatory environment.”

  • CoEHAR: Vapes Most Effective Quitting Tool

    CoEHAR: Vapes Most Effective Quitting Tool

    Image: CoEHAR

    A recent review conducted by the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) at the University of Catania found that e-cigarettes are more effective than other treatments for smoking cessation.

    Published in Drug and Alcohol Dependence, the study represents one of the most comprehensive analyses to date, evaluating 16 systematic reviews and encompassing data from 24 randomized controlled trials (RCTs).

    According to the authors, e-cigarettes outperformed other cessation treatments in eight out of 11 meta-analyses. No evidence was found to suggest that e-cigarettes are less effective than any alternative treatments. And while mixed results emerged when comparing ENDS to traditional nicotine replacement therapy, the overall trend favored ENDS for cessation efficacy.

    “The data from our umbrella review can support the integration of harm reduction strategies into public health policies in many countries,” said Renée O’Leary, lead author of the review, in a statement. “However, the review highlights a critical gap in existing cessation strategies, with long-term success rates for e-cigarettes remaining modest at 10 percent-12 percent and the effect of relapse has not been sufficiently studied. New treatments and approaches are urgently needed”.

    Despite these promising findings, the study also emphasizes the need for greater scientific rigor in the field. According to the authors, the analysis exposes significant reporting biases in many studies.

    “This study provides robust evidence supporting the potential of ENDS as an effective cessation aid, but it also calls for enhanced clinical guidelines and further exploration of long-term outcomes,” stated Riccardo Polosa, co-author and founder of CoEHAR.

  • Netherlands Urged to Reverse Tax Hike

    Netherlands Urged to Reverse Tax Hike

    A Dutch lawmaker wants to reverse a recent increase in tobacco excise duties to boost government revenue, reports The NL Times.

    On April 1, the Netherlands increased the excise duty per pack of 20 cigarettes from €5.85 to €7.81. A pack now costs more than €11. However, revenues from the measure have fallen short of expectations. Recent figures from the Ministry of Finance reveal that the tax increase will raise €550 million less than anticipated.

    Research by the RIVM showed that around 10 percent of smokers quit because of the more expensive cigarettes. The researchers also noted that the share of cigarettes from abroad increased from 24-28 percent to 35-39 percent.

    Concerned about the Netherland’s lower tax take, BBB parliamentarian Henk Vermeer urged the government to undo the measure, arguing that it would be “stealing from the treasury” if it failed to do so. According to the BBB, people crossing the border to buy their cigarettes likely do their other shopping there too. “That also means less revenue from VAT and corporate tax,” Vermeer said.

    Antismoking groups vehemently oppose Vermeer’s proposal, arguing that the purpose of the excise increase was not to raise money, but to discourage people from smoking.

     “Making cigarettes more expensive is very important and works,” KWF Kankerbestrijding Director Caral van Gils was quoted as saying. “There is more than enough scientific evidence for that.”

  • EU Pushing Again for Stricter Smoking Rules

    EU Pushing Again for Stricter Smoking Rules

    Credit: Doganmesut

    EU countries agreed Tuesday on a push for stricter anti-smoking rules, backing bans on smoking and vaping in many outdoor areas, including playgrounds and cafe patios.

    Health ministers from the bloc’s 27 nations meeting in Brussels adopted a recommendation inviting member states to crack down on secondhand smoke and vapor.

    “Today’s agreement is a crucial step towards our goal of a tobacco-free generation in Europe and is critical in protecting our children and young people from the harmful effects of second-hand smoke,” said the EU’s health commissioner, Oliver Varhelyi.

    The recommendation is non-binding, as health is the responsibility of individual member states. However, it indicates the policies governments could pursue in the future as they seek to reduce smoke-related deaths and ailments.

    It passed with all countries voting in favor apart from Germany and Greece, which abstained, underscoring some political divisions. Last week, the European Parliament voted against a similar text, according to media.

    The document approved on Tuesday calls on EU countries to extend restrictions in place for cigarettes to cover “emerging products”, such as heated tobacco devices and electronic cigarettes that are increasingly popular with young people. Governments should “provide effective protection” from aerosols emitted by these in indoor environments such as offices and public buildings.

    Following an initial proposal put forward by the European Commission in September, the text says such protection should also be granted in some outdoor areas. This, in practice, entails that all smoking should be banned in locations including swimming pools, beaches, zoos, rooftop bars, and restaurant terraces.

  • Slim Chances

    Slim Chances

    Image: Rostislav Sedlacek

    Harm reduction, smoking cessation and weight

    By Cheryl K. Olson

    Before Ozempic and Wegovy, before fen/phen and Xenical, there was nicotine. Cigarettes have long been viewed as appetite suppressants.

    In the early 20th century, advertisements manipulatively cautioned women to “Reach for a Lucky instead of a sweet” to “maintain that modern figure of fashion.” Modern-day military personnel, with employment prospects tied to fitness standards, often turn to tobacco for help.

    “Across the population, nicotine has undoubtedly been the most effective long-term weight control drug in use over the past century,” a review of research concluded. “Unfortunately, nicotine is delivered to most people via cigarette smoke, which is extraordinarily toxic.”

    Nicotine’s slimming effects can make smoking appealing to start and daunting to stop. “Those who are smokers are very afraid of quitting their smoking habit and not being able to control their appetite,” says Diego Verrastro, a physician and tobacco harm reduction advocate based in Argentina.

    A few years ago, Verrastro began encouraging his patients who suffer from obesity to switch to vaping. The results? “We have managed to get them to quit smoking and also lose weight,” he says. “And obviously reduce the risk and morbidity of both associated pathologies.”

    Noncombustible tobacco products are gaining notice as potentially less risky ways to exploit nicotine’s weight loss properties. Earlier this year, social media posts touted nicotine pouches (aka “O-Zyn-Pic”) as cheap alternatives to costly GLP-1 agonist medications.

    What do we know about reduced-risk products (RRPs) and weight? If RRPs can address two problems at once, as Verrastro suggests, why isn’t this getting more attention? 

    How Nicotine Affects Weight

    Nicotine influences eating and weight in multiple ways, from hormones to microbiomes to taste perceptions. The bottom line: Nicotine raises the metabolic rate while also depressing appetite. 

    One way to separate the effects of nicotine from smoking is to look at very low-nicotine (VLN) cigarettes. A smoking cessation trial using VLN cigarettes found that people randomized to the products (who actually used them) gained 1.2 kg over six weeks. In short, removing the nicotine from cigarettes deletes their weight control effects. Researchers noted that “the health benefits of quitting far outweigh the negative health consequences of post-cessation weight gain.”

    Although nicotine is the primary driver in weight reduction, puffing on a cigarette can also be a behavior substitute for eating. (Hence the quit-smoking advice to nibble on carrots or toothpicks.)

    Not everyone gains weight when they quit smoking, but most people do. Smoking puts the brakes on ordinary aging-related weight gain; that ends when the smoking stops. On average, successful quitters gain 4 kg or 5 kg within a year. Some gain a lot more. A 1991 U.S. national study found that after a decade, about one in 10 men and one in eight women gained over 13 kg. Being Black or smoking heavily (over 15 cigarettes a day) increased the risk for extra pounds.

    For some, that added weight contributes to type 2 diabetes and heart disease. Research shows that the health benefits of smoking cessation far exceed the health harms of weight gain. But many people who smoke aren’t willing to make that trade.

    Multiple studies show that fear of weight gain is a primary reason for delaying quit attempts, particularly among women. Also, gaining weight during or after the quitting process is linked to relapse.

    What has worked in the past to make stepping onto the scale less scary? Unfortunately, a Cochrane review of interventions for preventing weight gain after cessation found scant reason for optimism. Most studies were small, results varied widely, and the usual options were unhelpful. For example, varenicline does not limit weight gain. In short, there’s a large unmet need for new approaches.  

    Hints of Benefits

    For decades, there have been intermittent hints that noncombustible nicotine could help control weight. Back in 1988, while studying long-term smoking cessation, Peter Hajek and colleagues at the University of London found an interesting result. Among people who remained smoke-free at one year, those who stuck with nicotine gum had gained significantly less weight than their peers. At that point, most gum users were chewing just a few pieces per day. Moreover, the group of persistent gum users had been heavier smokers, who typically gain more weight.

    Sixteen years later, Brad Rodu and collaborators published results on a study of tobacco use and weight among men in northern Sweden. They found that quitting tobacco—whether cigarettes or snus—led to weight gain. However, those who quit smoking by switching to snus cut that gain significantly.

    Skip ahead 13 years. Vaping is now big news. Marewa Glover in New Zealand and colleagues queried, in the Journal of Nicotine & Tobacco Research, whether e-cigarettes could “be a new weapon in the battle of the bulge.” Along with the effects of nicotine noted above, they wondered if flavor options could positively affect satiety and food cravings. They also acknowledged that any potential for nonsmokers to start vaping for weight control could intensify the alarm of e-cigarette critics. 

    Evidence continues to trickle in. Cristina Russo, Riccardo Polosa and colleagues at the University of Catania have substantiated that e-cigarettes can mitigate weight issues. At one-year follow-up, former smokers who switched to vaping had gained a mere 1.5 percent of their baseline weight.

    “The strategy of recommending a switch to vaping to manage both nicotine dependence and appetite control aligns with our experience with smokers—and their fears of putting on too much weight,” says Polosa. “The potential for the dual benefit for these people cannot be underestimated. Helping them quit smoking, manage their weight and lower their overall risk and morbidity for both obesity and smoking-related conditions can be a significant achievement.” 

    Polosa’s group has completed a systematic review and meta-analysis of available research on the effects of electronic nicotine-delivery systems on weight for people who have either quit or reduced conventional smoking. Results are currently undergoing peer review.

    Might people who smoke be interested in using RRPs for weight management? In 2018, the ongoing Smoking Toolkit Study in England made inquiries. Only 5.7 percent of participants admitted to smoking for weight control reasons. Of respondents who currently smoked, just 8.8 percent had heard that vaping might help keep weight down. But one in eight said this feature would make them more likely to try e-cigarettes. Of people who already vaped, one in 22 said they did so to control weight.

    “If evidence that vaping could help users to control their weight during a quit attempt could be identified and communicated to smokers, they may be more inclined both to try e-cigarettes and to quit smoking,” study authors said.

    Why the Neglect?

    Why don’t we know more about the exciting potential for this dual benefit from novel nicotine products? Despite the documented need for better options, this issue hasn’t been a research priority. Most published studies that look at the health effects of reduced-risk products do not mention appetite or weight. The history of questionable cigarette marketing claims, and concerns about enticing tobacco nonusers, may play a role here.

    This low priority makes it difficult to fund new studies. About six years ago, researcher Erika Litvin Bloom of Brown University became interested in the effects of e-cigarettes on eating behavior. For example, she uncovered intriguing findings in survey data that people who smoked daily to prevent overeating were more likely to report some use of e-cigarettes. 

    “In particular, I was interested in whether sweet flavors like vanilla and cherry would have different effects than traditional tobacco and menthol flavors,” she says. Her grant applications to the National Institutes of Health to study these effects “got pretty good but not quite fundable scores” from the reviewers. After multiple tries, she gave up.

  • Belarus To Retain Control Over Tobacco

    Belarus To Retain Control Over Tobacco

    The tobacco business in Belarus will remain under state control, President Aleksandr Lukashenko announced on Dec. 2, 2024, according to BelTA.

    While approving the candidacy of Andrei Demidovets for the post of Director General of Minsk Kristall Group Holding Management Co., the president noted that alcohol and tobacco companies in Belarus are managed by the state. “We will stick to this course,” the head of state emphasized.  

    “Tobacco products, alcohol account for a big part of the budget and this sector closely related to people’s health,” Lukashenko noted. “I do not remember that state-owned enterprises have ever produced something of poor quality. If we have a complete mess on the market, we will have self-distilled vodka or other alcohol of poor quality produced in garages and sold on the market for cheap.

    “Therefore, the state control will remain over alcohol and tobacco in the country,” the president said.

  • Justices Appear Divided on Triton’s PMTA Denials

    Justices Appear Divided on Triton’s PMTA Denials

    The hearing took just over an hour. Today, the United States Supreme Court heard oral arguments in FDA v. Wages and White Lion Investments, LLC, a pivotal case concerning the Food and Drug Administration’s rejection of applications to market flavored nicotine vaping devices.

    The case is about much more than saving the vaping industry; it is also a landmark case for regulatory accountability related to public health and consumer choice. A decision is expected by the end of the Supreme Court’s term in June.

    At issue is whether the FDA acted arbitrarily and capriciously when denying numerous premarket tobacco product applications (PMTA), as alleged by the manufacturers and affirmed by the U.S. Court of Appeals for the 5th Circuit, which accused the FDA of a “regulatory switcheroo”. 

    Elizabeth Hicks, US Affairs Analyst of the Consumer Choice Center, stated that the case underscores the need for “fairness and transparency” in regulatory processes. “The FDA’s blanket denials have placed enormous hurdles on firms providing harm-reduction alternatives, potentially decimating an industry that millions of adult consumers rely on to transition away from smoking traditional cigarettes,” she said.

    The court heard the FDA’s defense of the agency’s rejection of two companies’ premarket tobacco product applications (PMTAs) to sell flavored vape products that it has determined pose health risks for young consumers. The justices took up the FDA’s appeal filed after a lower court ruled that the agency had failed to follow proper legal procedures under federal law when it denied the applications to bring their nicotine-containing products to market.

    In January, the full slate of 5th Circuit judges ruled 10-6 that the FDA had been arbitrary and capricious, in violation of a federal law called the Administrative Procedure Act, by denying the applications without considering plans by the companies to prevent underage access and use.

    Associate Justice Clarence Thomas called the FDA guidance “a moving target” that shifted throughout the process. Also, Associate Justice Neil Gorsuch stated that applicants were not granted conditions for jury trials in administrative cases, as the court outlined in SEC v. Jarkesy. Gorsuch also wondered if the agency had failed to give applicants fair notice that the rules had changed.

    The court has a 6-3 conservative majority that is often skeptical of federal agency decision-making.

    Their lawyers argue that the FDA changed its standard for considering flavored vapes in the middle of the process without giving applicants adequate warning.

    Kavanaugh also seemed to have sympathy for the FDA’s case. He said it was clear from the outset what the FDA’s position on issuing denial orders was: a focus on the harm to young people that flavored vape products bring. He noted that under the Tobacco Control Act, the FDA has the power to regulate tobacco products, with a special focus on youth.

    If, after weighing the evidence, the FDA rejects an application, “It’s kind of the end of it, isn’t it?” Kavanaugh asked.

    Hicks said the FDA’s rejection of Triton and Vapetasia’s applications demonstrates a failure to balance or even understand public health priorities and opportunities provided by less harmful nicotine products.

    “While we all agree on the need to keep these products out of the hands of young people, denying adult smokers access to safer alternatives like flavored vaping devices could have dire consequences for harm-reduction efforts,” Hicks said in a press release. “Regulatory decisions should be evidence-based, not rooted in unachievable or shifting standards that are unreasonable to provide.”

     Justice Elena Kagan said that applicants know that the FDA believes that flavored vapes are especially appealing to children and that they would need to overcome that presumption in their PMTA submissions.

    “I mean, there’s just not a lot of mystery here about what FDA was doing. You might disagree with that, because you think that, in fact, the world of 40-year-olds really wants to do blueberry vaping, but you can’t say that FDA hasn’t told you all about what it’s thinking in this respect,” Kagan told the companies’ lawyer, Eric Heyer.

    Heyer told the justices that if his clients win the case, there could be a change in the FDA’s approach, citing comments Trump has made that he would “save vaping.”

    Just before the hearing began, Tony Abboud, executive director of the Vapor Technology Association. said the High Court has the opportunity to examine and critique the farcical “wild goose chase” manufacturers have been led on over the years due to the FDA’s illegal and bad faith actions.

    “While VTA eagerly awaits the SCOTUS decision, VTA knows that a favorable ruling will not fix the systemic and ideological failures at FDA. VTA will continue to work closely with the incoming Trump Administration, which can quickly and decisively end all current litigation – and all future litigation that will follow a SCOTUS decision favorable to industry – by implementing a new tobacco products standard which establishes clear scientific guidelines for the authorization of products and a real pathway to a broad and diverse U.S. vaping industry,” Abboud said. “Biden FDA’s illegal actions, which have deprived Americans of less harmful nicotine alternatives and are crushing an innovative industry, must be comprehensively addressed immediately through the bold and decisive leadership of President-elect Trump.” 

  • Smoke-Free Resolution Rejected

    Smoke-Free Resolution Rejected

    The European Parliament rejected a resolution that would have equated vaping with smoking in outdoor spaces, according to the World Vapers’ Alliance (WVA).

    Michael Landl, director of the WVA, stated: “This decision demonstrates that facts and consumer choice can prevail over fearmongering and overregulation, dealing a blow to the creeping nanny state mentality that has too often characterized EU regulations. It shows that when citizens make their voices heard, and when policymakers are presented with clear evidence, positive outcomes are possible. This outcome sets a promising precedent for future EU policymaking, one that respects both public health goals and individual freedoms.”